{
  "timestamp": "20250103_002240",
  "model": "gpt-4o",
  "interaction_type": "direct_answer",
  "question_id": "4a02a891",
  "question_text": "Which of the following does not cause Insulin release-",
  "messages": [
    {
      "role": "system",
      "content": "You are a medical expert making decisions based on medical knowledge."
    },
    {
      "role": "user",
      "content": "You are a medical expert specializing in the field of Pharmacology.Please help answer this multiple choice question:\n\nQuestion: Which of the following does not cause Insulin release-\n\nOptions:\nopa. Rosiglitazone\nopb. Nateglinide\nopc. Glimipiride\nopd. Tobutamide\n\n        ### Output Format\n        Provide your response in valid JSON format:\n        {   \n            \"final_analysis\": \"Your concise analysis following the above structure\",\n            \"answer\": \"Option key from the available options (only key,like opa)\",\n            \"confidence\": Score between 0-100 based on alignment with established medical facts\n        }\n        "
    }
  ],
  "response": "```json\n{\n    \"final_analysis\": \"Rosiglitazone is a thiazolidinedione that works by increasing insulin sensitivity in peripheral tissues, rather than stimulating insulin release from the pancreas. In contrast, Nateglinide, Glimipiride, and Tolbutamide are all insulin secretagogues that stimulate the release of insulin from pancreatic beta cells.\",\n    \"answer\": \"opa\",\n    \"confidence\": 95\n}\n```",
  "metadata": {
    "topic": "Pharmacology",
    "is_multi_choice": true,
    "has_reasoning_chain": false,
    "has_enhanced_info": false,
    "model_config": "gpt-4o",
    "temperature": 0.0
  }
}